Directory
>
Kathleen Meyer
Kathleen Meyer
Vice President, Nonclinical Development | Sangamo Therapeutics, Inc.
Berkeley, California, United States
Kathleen Meyer
Summary
Kathleen Meyer is a highly accomplished Vice President of Nonclinical Development with over 20 years of experience in the biopharmaceutical industry. She specializes in toxicology and nonclinical safety evaluation, particularly in genomic medicines and biologics. Kathleen has a proven track record of successfully navigating regulatory landscapes in the US, EU, and Japan, advocating for innovative therapeutic strategies. Her expertise spans various therapeutic areas, including oncology, diabetes, and rare diseases. Kathleen is passionate about fostering collaboration and empowering teams, which is evident in her leadership roles across multiple organizations. She holds advanced degrees in Environmental Health Sciences and Toxicology from the University of California, Berkeley, underscoring her strong academic foundation. Outside of her professional pursuits, Kathleen is likely to be an advocate for mentorship in the sciences, aiming to inspire the next generation of scientists. Her extensive publication record reflects her commitment to advancing drug development methodologies and improving patient outcomes.
Kathleen Meyer
Work Experience
Vice President, Nonclinical Development at
Sangamo Therapeutics, Inc.
January 2017 - Present
Senior Director, Toxicology at
Sangamo Biosciences, Inc.
January 2014 - December 2016
Principal at
Dean Nonclinical Consulting, Inc.
February 2013 - December 2016
Principal Scientist at
BioMarin Pharmaceutical Inc.
March 2012 - February 2013
Senior Director, Preclinical Safety Evaluation at
XOMA Royalty
June 2009 - February 2012
Director, Preclinical Safety Evaluation at
Xoma
January 2008 - June 2009
Director, Toxicology at
Xoma
October 2005 - January 2008
Group Leader at
Xoma
January 2003 - January 2005
Principal Scientist at
Elan Pharmaceuticals
January 2001 - February 2003
Senior Scientist II at
Xoma
January 2003 - January 2003
Scientist at
Elan Pharmaceuticals
June 1997 - January 2001
Histologist/Pathology Department at
Syntex Research
January 1981 - January 1987
Kathleen Meyer
Education
University of California, Berkeley, Master Degree In Public Health (Mph)
University of California, Berkeley, Doctor Of Philosophy (Phd)
University of California, Berkeley, Bachelor Of Arts (Ba)
Frequently Asked Questions about Kathleen Meyer
What is Kathleen Meyer email address?
Kathleen Meyer's primary email address is *****@xoma.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Kathleen Meyer work for?
Kathleen Meyer is a Vice President, Nonclinical Development at Sangamo Therapeutics, Inc., a company specializing in Commercial physical research.
Where Kathleen Meyer graduated from?
Kathleen Meyer holds a degree in Specializing In Toxicology from University of California, Berkeley.
How can I directly contact Kathleen Meyer?
To contact Kathleen Meyer directly, you can use the email address *****@xoma.com. Complete contact information is available upon registration with Muraena.
Who is Kathleen Meyer?
Kathleen Meyer is a highly accomplished Vice President of Nonclinical Development with over 20 years of experience in the biopharmaceutical industry. She specializes in toxicology and nonclinical safety evaluation, particularly in genomic medicines and biologics. Kathleen has a proven track record of successfully navigating regulatory landscapes in the US, EU, and Japan, advocating for innovative therapeutic strategies. Her expertise spans various therapeutic areas, including oncology, diabetes, and rare diseases. Kathleen is passionate about fostering collaboration and empowering teams, which is evident in her leadership roles across multiple organizations. She holds advanced degrees in Environmental Health Sciences and Toxicology from the University of California, Berkeley, underscoring her strong academic foundation. Outside of her professional pursuits, Kathleen is likely to be an advocate for mentorship in the sciences, aiming to inspire the next generation of scientists. Her extensive publication record reflects her commitment to advancing drug development methodologies and improving patient outcomes.
Kathleen`s contact details
*****@xoma.com
******@sangamo.com
Colleagues
SVP Technical Operations
Executive Vice President Technical Operations
Vice President, Global Manufacturing and Supply Chain
VP, Head of Research and Technology
Vice President, Intellectual Property
Chief Executive Officer
Senior Vice President, General Counsel & Corporate Secretary
Chief Development Officer
Scientific Advisor
Vice President Autoimmune Franchise, Product Development